Karl‐Dimiter Bissig
Duke University(US)Center for Human Genetics(US)Institut thématique Génétique, génomique et bioinformatique(FR)University Gastroenterology(US)Duke Medical Center(US)Duke University Hospital(US)Applied Genetic Technologies (United States)(US)Genetic Technologies (Australia)(AU)
Publications by Year
Research Areas
CRISPR and Genetic Engineering, Hepatitis B Virus Studies, Virus-based gene therapy research, Trace Elements in Health, Pharmacogenetics and Drug Metabolism
Most-Cited Works
- → Human liver chimeric mice provide a model for hepatitis B and C virus infection and treatment(2010)332 cited
- → A High Proliferation Rate Is Required for Cell Reprogramming and Maintenance of Human Embryonic Stem Cell Identity(2010)319 cited
- → Repopulation of adult and neonatal mice with human hepatocytes: A chimeric animal model(2007)201 cited
- → Generation of model tissues with dendritic vascular networks via sacrificial laser-sintered carbohydrate templates(2020)141 cited
- → Reprogramming metabolic pathways in vivo with CRISPR/Cas9 genome editing to treat hereditary tyrosinaemia(2016)130 cited
- → Innovations, challenges, and minimal information for standardization of humanized mice(2020)126 cited